Skip to contentSkip to main content

Macular pigment evidence, AREDS2 boundaries and label safety

Lutein supplements: AREDS2 evidence, studied dose, food sources and safety

Lutein is concentrated in the retina, but a lutein capsule is not a general vision, screen protection or AMD prevention treatment.

The strongest clinical context is the complete AREDS2 formula for appropriately staged intermediate AMD, which contains 10 mg lutein and 2 mg zeaxanthin alongside vitamin C, vitamin E, zinc and copper. Lutein alone has much weaker outcome evidence, and combination ingredients create most important interaction and smoking warnings.1,2,3,4,5,8

Strong
Updated September 4, 202616 min readHuman evidence first

At a glance

Lutein

Overall evidence
Strongest for the complete AREDS2 formula in selected AMD; lutein alone has limited outcome evidence1,2,4,8StrongFinding: mixed results
Best-supported form
AREDS2 combination with 10 mg lutein plus 2 mg zeaxanthin for the right AMD stage1,3,4StrongFinding: benefit supported
AREDS2 studied dose
10 mg lutein plus 2 mg zeaxanthin daily, alongside vitamins C and E, zinc and copper1,3,4StrongFinding: established use
AMD onset
Supplements have not been shown to prevent AMD in people who do not already have it2,8StrongFinding: no meaningful benefit
Smoking warning
Choose beta-carotene-free AREDS2 if you currently smoke or used to smoke1,2,5,8StrongFinding: established use
Screen claims
Retinal light-absorption biology does not prove protection from general screen damage or eye strain2,8,10,11LimitedFinding: still unknown
Combination caution
Zinc, vitamin E and other ingredients can create interaction, bleeding or oncology concerns1,2,13,14StrongFinding: established use

Study findings describe groups, not a guaranteed result for one person.

Research and writing

LongevityMate Editorial Team

Editorial oversight

Lukas Dvorsky, Founder

Clinical review

Not yet assigned or claimed